Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CERK might contribute to inflammatory pain; Comments on Yu WL, Sun. Y (2015). CERK inhibition might be a good potential therapeutic target for diseases. Br J Pharmacol 172: 2165.

× No keyword cloud information.

11 in total

1. CERK inhibition might be a good potential therapeutic target for diseases.

Authors: Wei-Li Yu; Yun Sun
Journal: Br J Pharmacol Date: 2015-03-16 Impact factor: 8.739

Review 2. Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain.

Authors: Daniela Salvemini; Timothy Doyle; Michaela Kress; Grant Nicol
Journal: Trends Pharmacol Sci Date: 2013-01-12 Impact factor: 14.819

3. CERK might contribute to inflammatory pain; Comments on Yu WL, Sun. Y (2015). CERK inhibition might be a good potential therapeutic target for diseases. Br J Pharmacol 172: 2165.

Authors: Jin-lu Huang; Yan Huo; Li-li Wan; Quan-jun Yang; Jie Li; Cheng Guo
Journal: Br J Pharmacol Date: 2016-04 Impact factor: 8.739

4. The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death.

Authors: Oleksandr Pastukhov; Stephanie Schwalm; Uwe Zangemeister-Wittke; Doriano Fabbro; Frederic Bornancin; Lukasz Japtok; Burkhard Kleuser; Josef Pfeilschifter; Andrea Huwiler
Journal: Br J Pharmacol Date: 2014-12 Impact factor: 8.739

5. Characterization of a ceramide kinase activity from human leukemia (HL-60) cells. Separation from diacylglycerol kinase activity.

Authors: R N Kolesnick; M R Hemer
Journal: J Biol Chem Date: 1990-11-05 Impact factor: 5.157

6. Ceramide kinase deficiency improves diet-induced obesity and insulin resistance.

Authors: Susumu Mitsutake; Tomomi Date; Hazuki Yokota; Masako Sugiura; Takafumi Kohama; Yasuyuki Igarashi
Journal: FEBS Lett Date: 2012-03-27 Impact factor: 4.124

7. Ceramide kinase promotes tumor cell survival and mammary tumor recurrence.

Authors: Ania W Payne; Dhruv K Pant; Tien-Chi Pan; Lewis A Chodosh
Journal: Cancer Res Date: 2014-08-27 Impact factor: 12.701

8. Ceramide kinase contributes to proliferation but not to prostaglandin E2 formation in renal mesangial cells and fibroblasts.

Authors: Oleksandr Pastukhov; Stephanie Schwalm; Isolde Römer; Uwe Zangemeister-Wittke; Josef Pfeilschifter; Andrea Huwiler
Journal: Cell Physiol Biochem Date: 2014-06-16

9. New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase.

Authors: Francesca Bini; Alessia Frati; Mercedes Garcia-Gil; Chiara Battistini; Maria Granado; Maria Martinesi; Marco Mainardi; Eleonora Vannini; Federico Luzzati; Matteo Caleo; Paolo Peretto; Antonio Gomez-Muñoz; Elisabetta Meacci
Journal: Neuropharmacology Date: 2012-05-08 Impact factor: 5.250

10. Ceramide kinase is required for a normal eicosanoid response and the subsequent orderly migration of fibroblasts.

Authors: Dayanjan S Wijesinghe; Matthew Brentnall; Jennifer A Mietla; L Alexis Hoeferlin; Robert F Diegelmann; Lawrence H Boise; Charles E Chalfant
Journal: J Lipid Res Date: 2014-05-13 Impact factor: 5.922

2 in total

1. CERK might contribute to inflammatory pain; Comments on Yu WL, Sun. Y (2015). CERK inhibition might be a good potential therapeutic target for diseases. Br J Pharmacol 172: 2165.

Authors: Jin-lu Huang; Yan Huo; Li-li Wan; Quan-jun Yang; Jie Li; Cheng Guo
Journal: Br J Pharmacol Date: 2016-04 Impact factor: 8.739

Review 2. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.

Authors: Nitai C Hait; Aparna Maiti
Journal: Mediators Inflamm Date: 2017-11-15 Impact factor: 4.711

2 in total